GSK-4528287

N/A

Report date: 2025/12/19 17:12:44

Base Information

Drug NameGSK-4528287

Drug Alias NameGSK4528287GSK-4528287

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Interleukin-23Interleukin 18 inhibitors

TargetsInterleukin-23Interleukin 18

Therapy Area/IndicationsColitis, Ulcerative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsColitis, Ulcerative

Inactive IndicationsN/A

Other Information

ATC CodeN/A